Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Asset disposition
Inv. presentation
Appointed director
Quarterly results
CC transcript

HUMAN GENOME SCIENCES INC (HGSI) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2013 SC 13G/A TCW GROUP INC reports a 0% stake in Human Genome Sciences, Inc.
02/13/2013 SC 13G/A Capital Research Global Investors reports a 0% stake in Human Genome Sciences, Inc
09/10/2012 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/17/2012 4/A Watkins Thomas (CEO) has filed a Form 4 on HUMAN GENOME SCIENCES INC
Txns: Gifted 2,000 shares @ $0
Bought 1,030 shares @ $20.62, valued at $21.2k
Gifted 5,000 shares @ $0
Bought 3,364 shares @ $6.32, valued at $21.3k
Gifted 167,000 shares @ $0
Unknown transaction of 10,469 shares @ $14.25, valued at $149.2k
08/13/2012 15-12B Form 15-12B - Securities registration termination [Section 12(b)]
08/13/2012 EFFECT Form EFFECT - Notice of Effectiveness
08/09/2012 CT ORDER Form CT ORDER - Confidential treatment order
08/09/2012 3 Connelly Deirdre P (President & CEO) has filed a Form 3 on HUMAN GENOME SCIENCES INC
08/09/2012 3 Connor Roger (Director) has filed a Form 3 on HUMAN GENOME SCIENCES INC
08/09/2012 3 Koczynski Chester (Director) has filed a Form 3 on HUMAN GENOME SCIENCES INC
08/09/2012 3 Rawcliffe Adrian (Chief Financial Officer) has filed a Form 3 on HUMAN GENOME SCIENCES INC
08/09/2012 3 Redfern David (Director) has filed a Form 3 on HUMAN GENOME SCIENCES INC
08/09/2012 3 Tomlinson Ian (Director) has filed a Form 3 on HUMAN GENOME SCIENCES INC
08/09/2012 3 Troy Daniel (Secretary) has filed a Form 3 on HUMAN GENOME SCIENCES INC
08/09/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
08/09/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
08/09/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
08/09/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
08/09/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
08/09/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
08/09/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
08/09/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
08/09/2012 POS AM Form POS AM - Post-Effective amendments for registration statement
08/08/2012 8-K Quarterly results
08/03/2012 4 GLAXOSMITHKLINE PLC (10% Owner) has filed a Form 4 on HUMAN GENOME SCIENCES INC
Txns: Bought 5,686,715 shares @ $14.25, valued at $81M
Bought 3,413,699 shares @ $14.25, valued at $48.6M
Bought 59,232,487 shares @ $14.25, valued at $844.1M
08/03/2012 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
08/03/2012 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
08/01/2012 4 GLAXOSMITHKLINE PLC (10% Owner) has filed a Form 4 on HUMAN GENOME SCIENCES INC
Txns: Bought 4,934,743 shares @ $14.25, valued at $70.3M
Bought 1,788,186 shares @ $14.25, valued at $25.5M
08/01/2012 3 Form 3 - Initial statement of beneficial ownership of securities
08/01/2012 8-K Entry into a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an...
08/01/2012 4 Watkins Thomas (CEO) has filed a Form 4 on HUMAN GENOME SCIENCES INC
Txns: Gifted 166,075 shares @ $14.25, valued at $2.4M
Disposed/sold 400,000 options to buy @ $10.62, valued at $4.2M
Disposed/sold 500,000 options to buy @ $4.92, valued at $2.5M
Disposed/sold 500,000 options to buy @ $0.52, valued at $260k
Disposed/sold 360,000 options to buy @ $8.23, valued at $3M
Disposed/sold 325,000 options to buy @ $10.89, valued at $3.5M
Disposed/sold 1,250,000 options to buy @ $10.47, valued at $13.1M
08/01/2012 4/A Simpson Curran (Sr. VP, Operations) has filed a Form 4 on HUMAN GENOME SCIENCES INC
Txns: Disposed/sold 8,334 shares @ $14.25, valued at $118.8k
Disposed/sold 18,000 shares @ $14.25, valued at $256.5k
08/01/2012 4 YOUNG ROBERT C (Director) has filed a Form 4 on HUMAN GENOME SCIENCES INC
Txns: Disposed/sold 4,166 shares @ $14.25, valued at $59.4k
Unknown transaction of 13,834 shares @ $14.25, valued at $197.1k
Disposed/sold 18,852 shares @ $14.25, valued at $268.6k
Disposed/sold 16,000 options to buy @ $11.33, valued at $181.3k
Disposed/sold 16,000 options to buy @ $10.7, valued at $171.2k
Disposed/sold 13,170 options to buy @ $2.09, valued at $27.5k
Disposed/sold 16,000 options to buy @ $5.97, valued at $95.5k
Disposed/sold 16,000 options to buy @ $14.23, valued at $227.7k
Disposed/sold 22,000 options to buy @ $8.68, valued at $191k
08/01/2012 4 KARABELAS ARGERIS N (Director) has filed a Form 4 on HUMAN GENOME SCIENCES INC
Txns: Disposed/sold 4,166 shares @ $14.25, valued at $59.4k
Unknown transaction of 17,776 shares @ $14.25, valued at $253.3k
Disposed/sold 16,000 options to buy @ $11.33, valued at $181.3k
Disposed/sold 16,000 options to buy @ $10.7, valued at $171.2k
Disposed/sold 16,000 options to buy @ $2.09, valued at $33.4k
Disposed/sold 16,000 options to buy @ $5.97, valued at $95.5k
Disposed/sold 16,000 options to buy @ $14.23, valued at $227.7k
Disposed/sold 48,000 options to buy @ $10.69, valued at $513.1k
Disposed/sold 16,000 options to buy @ $11.51, valued at $184.2k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy